Cercle, a women’s AI-driven healthcare, has secured $6 million in seed funding to enhance its AI-based health data platform. This platform leverages artificial intelligence to organize extensive de-identified healthcare data, with an initial emphasis on fertility. Launched in November 2023, the Cercle Biomedical Graph has already been adopted by US Fertility, Boston IVF, and Eurofins Genoma.
Cercle announced that the funding will support growth in areas outside of the fertility market, improve the platform, and strengthen its large language model (LLM) capabilities. The company’s goal is to expand its clientele in various areas of women’s healthcare, such as menopause, women’s oncology, and rare diseases that affect women more significantly.
The $6 million seed round was led by the Outsiders Fund, with contributions from FemHealth Ventures, CGHealth Ventures, and Rogue Women’s Fund. Additionally, the round included investments from Sheryl Sandberg, former Meta executive, and her husband Tom Bernthal’s venture fund, which previously led Cercle’s $4.2 million pre-seed round at its launch in November 2023.
Ashley Finch chief operations officer at Cercle said, “Women’s healthcare is under-researched, underfunded, and underserved. Our mission at Cercle is simple and clear: to leverage the power of AI to generate insights from women’s health data to drive efficiencies for providers, develop drugs faster, and improve care for patients.”
George Easley, Principal at Outsiders Fund said, “Cercle is a truly exciting innovator at the intersection of AI and women’s healthcare. Cercle’s leadership team possesses a rare set of technical and operational skills that uniquely positions them to reimagine the uses of AI in and the data infrastructure of women’s healthcare. The company’s best-in-class infrastructure, LLM interface, and ML / AI models provide serious leverage to clinicians and healthcare operators alike. We are proud to lead this seed round and excited about what the future holds for Cercle.”
Dr. Eduardo Hariton, VP of Strategic Initiatives at US Fertility and Managing Director of the Innovation Fund said, “Cercle’s unique AI platform has meaningfully enhanced both our business operations and clinical workflows. Analyzing raw data for actionable insights is labor-intensive and costly. Cercle’s AI platform enables us to extract these insights more efficiently and at scale, leading to both better outcomes for our business and a better experience for our patients.”
